- Addressing infants' phototherapy needs through advanced LED technology that's effective and easy to use
Dubai, UAE; January 25, 2012: More than 50% of all infants, both pre-term and full-term, are at risk of hyperbilirubinemia, a condition caused when there is too much bilirubin in the blood. To address this condition, GE Healthcare, the healthcare business of GE (NYSE:GE), has introduced a LED phototherapy product to their Lullaby portfolio, further addressing the needs of infants around the world.
The Lullaby LED phototherapy system is displayed at GE's stand at Arab Health 2012, the region's premier health sector exhibition to be held from January 23 to 26 at the Dubai International Convention & Exhibition Center.
The system equips clinicians with a tool to deliver high intensity phototherapy to treat infants with hyperbilirubinemia. By utilizing LED technology, power consumption and the overall replacement costs are significantly reduced, resulting in up to 80% energy savings and a 50x extended bulb life, making Lullaby LED phototherapy an investment for today and tomorrow.
"Providing clinicians with the right tools to address infants' healthcare needs, like hyperbilirubinemia is the foundation of our business," said Aziz Koleilat, General Manager at GE Healthcare in the Middle East region. "The Lullaby LED phototherapy system is a great addition to our Lullaby performance product portfolio and offers a safe, efficient and cost effective solution to address one of the most common ailments in newborns."
In addition to the overall savings, Lullaby LED phototherapy: is quiet, being designed without a fan and operating over 50% quieter than IEC guidelines; provides a tightly focused wavelength for maximizing bilirubin metabolism; has a high irradiance level allowing for tailored treatment for each infants' needs and delivers uniform light distribution over the total surface area of the body, maximizing bilirubin breakdown.
Through the combination of optimal wavelength, high intensity and uniform light distribution yields a 28% faster total serum bilirubin breakdown2.
GE Healthcare has several decades of presence in the Middle East region, and its technologies support an overwhelming majority of hospitals. Now in its 37th year, Arab Health is expected to host over 70,000 healthcare professionals, and will feature over 3,000 companies from around the world. Visit GE Healthcare's pavilion, which will be located in Sheikh Saeed Hall - Stand No S3B10.
Kelly Home
ASDA’A Burson-Marsteller
[email protected]
+971 4 4507 600
Nivine William
ASDA’A Burson-Marsteller
[email protected]
+971 4 4507 600